As part of its ongoing commitment to demonstrate the crucial role of the biopharmaceutical industry in addressing the COVID-19 crisis, EFPIA has produced a video to communicate the lengths members are going to ensure supply to patients.
The video shows how the entire industry is working around the clock to mitigate the impact of COVID-19 on the supply network. Staff in manufacturing and distribution centres are working relentlessly to ensure patients get the medicine they need.
The unprecedented impact of the pandemic has created new challenges to the supply chain. Manufacturing and distribution centres have had to rapidly adapt to temporary lockdowns by ensuring essential colleagues could keep production and delivery going. Travel restrictions for key staff, reduced air-freight capacity, export bans on critical medicines, increased demand for medicines used to treat COVID-19 patients and stockpiling by hospitals, by individual citizens or by governments, all put pressure on a medicine supply system designed to work across borders.